52-Week Phase 3 Study Found Investigational Drug Dapagliflozin Plus Metformin Similar to Glipizide Plus Metformin in Improving Glycosylated Hemoglobin (HbA1c) in Adults with Type 2 Diabetes Mellitus | Business Wire

Links shared publicly online about this topic.

  • 848
    total visits

52-Week Phase 3 Study Found Investigational Drug Dapagliflozin Plus Metformin Similar to Glipizide Plus Metformin in Improving Glycosylated Hemoglobin (HbA1c) in Adults with Type 2 Diabetes Mellitus | Business Wire

businesswire.com —

52-Week Phase 3 Study Found Investigational Drug Dapagliflozin Plus Metformin Similar to Glipizide Plus Metformin in Improving Glycosylated Hemoglobin

View full resource at businesswire.com

Tags: Diabetes Type 2 Medication, Diabetes Medication, Type 2 Diabetes, Drug, Phase 3 Clinical Trial, Glucophage, Glucotrol

  • Share

Most Recently Shared on September 25, 2010 at 7:53 am By:

Urology_Wisdom Urology & Nephrology

52-Week Phase 3 Study Found Investigational Drug Dapagliflozin Plus Metformin Similar to Glipizide Plus Metformin ... http://bit.ly/9HYgGl

2 years ago...

Reply

Retweet

Favorite

Advertisement